U.S. Markets open in 4 hrs 17 mins

Compugen Ltd. (CGEN.TA)

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
Add to watchlist
1,206.00-22.00 (-1.79%)
As of 11:16AM IDT. Market open.

Compugen Ltd.

Azrieli Center
Building D
Holon 5885849
972 3 765 8585

Full Time Employees98

Key Executives

Dr. Anat Cohen-Dayag Ph.D.Chief Exec. Officer, Pres and Director575.36kN/A50
Mr. Ari KrashinChief Financial and Operating Officer353.38kN/A44
Dr. Zurit Levine Ph.D.VP of Research & Discovery259.85kN/A49
Dr. John J. Hunter Ph.D.VP of Antibody R&D338.53kN/A54
Susanna ChauDirector of Investor Relations and Corp. CommunicationsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ILS.


Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company’s pipeline primarily includes early and preclinical stage immuno-oncology programs based on novel drug targets, such as immune checkpoint and myeloid protein target candidates to harness the immune system to provide treatment solutions in the areas of unmet medical needs in various cancer types and patient populations. Its antibody drug conjugate target candidates comprise CGEN-15001T, CGEN-15022, CGEN-15029, and CGEN-15137 for oncology; and therapeutic proteins include CGEN-15001, a fusion protein for autoimmune diseases, as well as CGEN myeloid target. The company was incorporated in 1993 and is headquartered in Holon, Israel.

Corporate Governance

Compugen Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.